Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Steroids for Early PARDS
NCT04064684Phase 2Terminated
- Sponsor
- UTHealth Houston
- Start
- Feb 2020
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide in Pediatric Acute Respiratory Distress Syndrome (PARDS), sponsored by UTHealth Houston. Started Feb 2020; status: terminated.
02
Drugs
budesonide
03
Conditions
Pediatric Acute Respiratory Distress Syndrome (PARDS)
Beyond the preview
Go deeper on NCT04064684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04064684.